Yüklüyor......
Limitations in Clinical Trials Leading to Anticancer Drug Approvals by the US Food and Drug Administration
IMPORTANCE: While there have been multiple assessments of clinical trials leading to anticancer drug approvals by the US Food and Drug Administration (FDA), the cumulative percentage of approvals based on trials with a limitation remains uncertain. OBJECTIVE: To assess the percentage of clinical tri...
Kaydedildi:
| Yayımlandı: | JAMA Intern Med |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Medical Association
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7296449/ https://ncbi.nlm.nih.gov/pubmed/32539071 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamainternmed.2020.2250 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|